Surgical treatment of atrial fibrillation using argon-based cryoablation during concomitant cardiac procedures. Academic Article uri icon

Overview

abstract

  • BACKGROUND: The development of ablative energy sources has simplified the surgical treatment of atrial fibrillation (AF) during concomitant cardiac procedures. We report our results using argon-based endocardial cryoablation for the treatment of AF in patients undergoing concomitant cardiac procedures. METHODS AND RESULTS: Sixty-three patients with AF who were undergoing concomitant cardiac procedures had the same left atrial endocardial lesion set using a flexible argon-based cryoablative device. Mean age was 65.1+/-1.3 years. Sixty-two percent had permanent AF, whereas 38% had paroxysmal AF. Mean duration of AF was 30.5+/-4.8 months. Mean left atrial diameter was 5.5+/-0.1 cm. Mean ejection fraction was 45+/-1.4%. All endocardial lesions were performed for 1 minute once tissue temperature reached -40 degrees C. Follow-up echocardiograms were obtained to determine freedom from AF. Kaplan-Meier analysis demonstrated an 88.5% freedom from AF rate at 12 months. Ablation time was 16.8+/-0.6 minutes. There were no in-hospital deaths and no strokes. Twelve patients (19%) required postoperative permanent pacemaker placement. CONCLUSIONS: Cryoablation using this flexible argon-based device for the treatment of AF during concomitant cardiac procedures was safe and effective, with 88.5% of patients free from AF at 12 months.

publication date

  • August 30, 2005

Research

keywords

  • Atrial Fibrillation
  • Cardiac Surgical Procedures
  • Cryosurgery

Identity

Scopus Document Identifier

  • 24644489084

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.104.524363

PubMed ID

  • 16159799

Additional Document Info

volume

  • 112

issue

  • 9 Suppl